Heart Rhythm Society Introduced to New Method for Optimizing Cardiac Resynchronization Therapy During Exercise
Heart Rhythm Society Introduced to New Method for Optimizing Cardiac Resynchronization
Therapy During Exercise. The new FDA-approved Shape-HF™ Cardiopulmonary Testing System "can make a dramatic difference in treating CRT patients." Dr. Abraham Kocheril, Professor of Medicine and ...
Boston Scientific Announces CE Mark Approval for Next-Generation Cardiac Resynchronization Therapy Defibrillator
NATICK, Mass., Dec. 28 /PRNewswire-FirstCall/ -- Boston Scientific
Corporation (NYSE: BSX ) today announced CE Mark approval for its LIVIAN(TM)
therapy defibrillator (CRT-D), which treats heart
failure and helps protect patients at risk of sudden cardiac death. The
Study puts brakes on extending indications for cardiac resynchronization therapy
A randomized, controlled, multi-center trial has found that cardiac resynchronization
therapy produced no improvement in peak oxygen uptake during exercise testing, the trial's primary endpoint, in patients with Class III heart failure, including mechanical problems that disrupt the heart's normal...
University of Zurich Announces Worldwide Clinical Trial of Cardiac Resynchronization Therapy
The University of Zurich announces an investigator initiated large-scale prospective randomized controlled clinical trial to assess the clinical impact of Cardiac Resynchronization
Therapy (CRT) in heart failure patients.
The worldwide study, called "Echocardiography guided Cardiac Resync...
EUROPACE raises remote monitoring profile
Cardiovascular implantable electronic devices (CIEDs) - which include cardiac pacemakers, implantable cardioverter defibrillators (ICD), cardiac resynchronization
therapy (CRT) devices, implantable cardiovascular monitors and implantable loop recorders - have now been developed with numerous programmable feature...
New Shape-HF™ Cardiopulmonary Testing System to be on Display at 2009 American Association of Heart Failure Nurses Annual Meeting
...he individual patient and track patient progress. In addition, using the Shape-HF™ to measure changes in patient breathing efficiency as cardiac resynchronization
therapy (CRT) settings are adjusted allows physicians to assess the physiological effect of therapy in real time while the patient is exercising at a ...
Boston Scientific Announces European Approval and First Implants of New Defibrillation Lead System Designed to Simplify the Surgical Process
...) 4-SITE defibrillation lead system. Defibrillation leads are insulated wires that connect an implantable cardioverter defibrillator (ICD) or cardiac resynchronization
therapy defibrillator (CRT-D) to the heart and, when needed, deliver life-saving therapy.
The ENDOTAK RELIANCE 4-SITE lead system is designed t...
Patients Call for Continued FDA Preemption Authority
"Without my medical device, I would not be here today," said Laura Doud of Arlington, Virginia, who received life-saving implantation of cardiac resynchronization
therapy with defibrillation in 2004 after suffering almost fatal viral cardiomyopathy. "If the proposed legislation were passed, would the lawsuits fa...
Cardiac Patients Take NASA Super Plastic to Heart
...xygen. It is a chronic and progressive condition that affects more than five million Americans and more than 22 million individuals worldwide. Cardiac resynchronization
therapy, or CRT, is designed to coordinate the contraction of the heart's two lower chambers and improve the heart's efficiency to increase blood flow...
Doctor's Training Affects Defibrillator Implant Results
...iologists," Curtis said.
Another marked difference found in the study concerned people who require an implanted defibrillator that provides cardiac resynchronization
therapy (CRT-D). "These are patients with heart failure, in which the heart is not only weak and inefficient but also beats in a disorganized way," Cu...
Resynchronization in Medical Technology
New Therapy Found to Prevent Heart Failure
...th heart disease who received an implanted cardiac resynchronization
therapy device with defibrillator (CRT-D) versus p...atic Defibrillator Implantation Trial with Cardiac resynchronization
Therapy) is a clinical trial that enrolled more th...s and heart failure. The new generation of cardiac resynchronization
therapy defibrillators (CRT-Ds) was designed to st...
MADIT-CRT Trial Meets Primary Endpoint
...t its primary endpoint. Preliminary results show Boston Scientific cardiac resynchronization
therapy defibrillators (CRT-Ds) to be associated with a significant 29 perc...ely by Boston Scientific, demonstrates that early intervention with cardiac resynchronization
therapy can slow the progression of heart failure. It is the world's large...
Boston Scientific Data Show Real-World Survival Rates for Implantable Cardiac Device Patients Exceed Rates From Clinical Trials
...the LATITUDE(R) Patient Management system. Five-year survival rate data for patients using implantable cardioverter defibrillators (ICDs) and cardiac resynchronization
therapy defibrillators (CRT-Ds) were presented at the Heart Rhythm Society Scientific Sessions in Boston by Leslie Saxon, M.D., F.A.C.C., Chief, Cardi...
First Swiss Patients Treated with the Percutaneous MitraClip(R) System
...art failure is a devastating disease, significantly more common than cancer and has the same poor life-expectancy. Implantable devices such as cardiac resynchronization
therapy have improved the quality of life of these patients. Now with percutaneous mitral valve repair, I am confident we can expand our treatment pos...
Boston Scientific Announces CE Mark Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death
...TICK, Mass., Jan. 22 /PRNewswire-FirstCall/ -- Boston Scientific
Corporation (NYSE: BSX ) today announced CE Mark approval for its COGNIS(TM)
therapy defibrillator (CRT-D) and TELIGEN(TM)
implantable cardioverter defibrillator (ICD). These devices represent
entirely new platforms to treat he...
Resynchronization in Medical Products
Kronos LV-T Cardiac Resynchronization Therapy Defibrillator (CRT-D) System
Description: RV Tracking for 100 % Resynchronization...
Company:Biotronik GmbH & Co.
InSync III Cardiac Resynchronization System
Description: The Medtronic InSync III Model 8042 increases therapy versatility with faster programming, and the ability to optimize sensing, pacing and cardiac output. The InSync III system also offers unmatched insight through key heart failure diagnostics and monitoring trends, to efficiently track a patient'...
Description:...-port (one atrial and two ventricular) multi-chamber device capable of stimulating the heart in a biventricular or left-ventricular fashion to promote resynchronization
and improved hemodynamic performance in patients with heart failure....
Company:St. Jude Medical, Inc.
Description:... InSync Sentry cardiac resynchronization
therapy (CRT) defibrillator system. It is the worlds first implantable medical therapy offering automatic fluid status monitoring in the thoracic cavi...
Attain OTW Model 4194 Bi-Polar
Description:...e Attain 4194 Bipolar over-the-wire left-heart lead is for use with cardiac resynchronization
systems. This new steroid-eluting lead has an angled shape and can be inser...ft-heart leads designed for use with the Medtronic InSync family of cardiac resynchronization
therapy (CRT) pacemaker and defibrillator systems....
Atlas® + HF ICD
Description:... the best in patient safety, programming flexibility, comfort, and quality of life. The Atlas+ HF ICD is the worlds most powerful ICD offering cardiac resynchronization
therapy (CRT), and it packs its power into a compact, 81 gram and 40 cc physiologic-shaped can. In addition to its high energy, the device offers high...
Company:St. Jude Medical, Inc.
Epic™ HF ICD
Description:...ld's smallest and lightest 30 joule (delivered energy) biventricular ICD. Small size doesn't mean sacrifice, though. The Epic HF ICD features advanced resynchronization
parameters along with 34 joules stored/30 joules delivered energy and a 7.5 second charge time....
Company:St. Jude Medical, Inc.
Description:... With the Tupos LV/A+, the single-lead principle has been applied to cardiac resynchronization
therapy for the first time. The complete system, which consists of the Tupos LV/A+ and the five-polar Kainox A+ lead, minimizes the scope of surgery a...
Company:Biotronik GmbH & Co.
Description:... The Medtronic InSync ICD cardiac resynchronization
and ICD device offers 34 Joule therapy in 7 seconds (BOL). The unit's RV only sensing provides no opportunity for double counting of RV and LV depolar...
Contak® Renewal™ 3
Description:... The Guidant Contak Renewal 3 cardiac resynchronization
therapy defibrillator provides ventricular tachyarrhythmia therapy and cardiac resynchronization
therapy. Features: Independently programmable right ventricular (RV) and le...
Resynchronization in Medical Dictionary
...in which the heart can no longer pump enough blood to ... Cardiac resynchronization
therapy - CRT - for heart failure ... Cardiac resynchronization
therapy - CRT. This new heart failure treatment also reduces mortalit...
Resynchronization in Biological News
Syntermed licenses Emory ERTb software for enhanced cardiac imaging
...n, including the recent FDA cleared SyncTool™, which is designed to more accurately select heart failure patients who would benefit from cardiac resynchronization
Garcia is the scientific founder and chief scientific advisor of Syntermed. The company is co-owned in part by Emory and Georgia Tech...
Implanted Devices Detect High-Risk Heart Failure Patients
...e, according to researchers at Duke University Medical Center.
Besides maintaining optimal electrical stimulation to the heart, these CRT-D (cardiac resynchronization
therapy with defibrillation) devices are giving cardiologists a new view of subtle changes in a key measurement of heart health -- heart rate variabil...
Resynchronization in Biological Technology
Boston Scientific Announces European Approval for Its LATITUDE(R) Patient Management System
...ersion of the LATITUDE system is compatible with the Company's wireless TELIGEN(R) implantable cardioverter defibrillator (ICD) and COGNIS(R) cardiac resynchronization
therapy defibrillator (CRT-D), the world's smallest and thinnest high-energy devices.
The first enrollments of European patients onto the LA...
Boston Scientific to Donate Cardiac Rhythm Management Devices to Heartbeat International for Implantation in Needy Patients
...ounced that it has agreed to donate Cardiac Rhythm Management (CRM) devices, including pacemakers, implantable cardioverter defibrillators and cardiac resynchronization
therapy devices to Heartbeat International, a non-profit organization dedicated to providing CRM devices and medical care at no charge to needy patien...
Boston Scientific Announces Company Schedule for Heart Rhythm Society Scientific Sessions
...and the ALTITUDE Clinical Science Program. These presentations will provide new insights for implantable cardioverter defibrillator (ICD) and cardiac resynchronization
therapy defibrillator (CRT-D) patients.
Schedule of Events (all times are Eastern Time)
Tuesday, May 12
Cardiac Rhythm Man...
University of Illinois Medical Center in Chicago First Hospital to Install Innovative Shape-HF™ Cardiopulmonary Testing System
...tems. This makes it possible for the physician to evaluate therapy options for the individual patient and track patient progress. In addition, cardiac resynchronization
therapy (CRT) has become a mainstay in treating patients with severe heart failure when alternative treatment options have been exhausted. According t...
Boston Scientific Announces FDA Approval of New Heart Failure Lead
...tion (NYSE: BSX ) today announced U.S. Food and Drug Administration
(FDA) approval of its ACUITY(R) Spiral left ventricular lead for use with
therapy defibrillators (CRT-D) and cardiac
resynchronization therapy pacemakers (CRT-P), both of which treat heart
failure. The ACUITY Spiral lead is ...
Boston Scientific Announces Program to Analyze Latitude(R) Patient Monitoring Data
...e initiative will use the substantial LATITUDE data to
seek answers to common questions related to implantable cardiac
defibrillator (ICD) and cardiac resynchronization
(CRT-D) device therapy. The ALTITUDE initiative will be managed in
collaboration with an external physician panel of thought lea...
Boston Scientific Announces Japanese Approval of Heart Failure Lead
...) today announced Japanese Ministry of Health, Labor
and Welfare (MHLW) approval of its ACUITY(R) Steerable left ventricular
lead for use with cardiac resynchronization
therapy (CRT) devices, which
treat heart failure. The Company also received reimbursement approval for
the lead from the National Health Insurance Sys...
Boston Scientific Announces European Approval of New Heart Failure Lead
Spiral left ventricular lead for use with cardiac resynchronization
defibrillators and cardiac resynchronization
therapy pacemakers, both of
which treat heart fail... factor in providing patients
with optimal cardiac resynchronization
therapy," said Fred Colen, Executive
Boston Scientific Announces Three FDA Product Approvals for Its Cardiac Rhythm Management Business
...otect patients at risk of sudden cardiac death
-- The LIVIAN(TM) cardiac resynchronization
therapy defibrillator (CRT-D), which provides cardiac resynchronization
and defibrillation therapies in one device
-- An upgraded LATITUDE(...
Stereotaxis Appoints David Burkhardt, M.D. as Chief Medical Officer
...ne as an Electrophysiologist at the Cleveland Clinic.
His specialties include remote navigation, new technology assessment and
optimization of Cardiac resynchronization
Therapy. In 2005, he was
appointed Associate Program Director at the Cleveland Clinic. He has
authored or co-authored over 30 peer-reviewed publicatio...